Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Referanser til kreft i bukhinnen

  1. Ronnett BM, Shmookler BM, Sugarbaker PH, Kurman RJ. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary. Anat Pathol 1997; 2:197-226.
  2. Moran BJ, Meade B, Murphy E. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients. Colorectal Dis 2006; 8(7):544-50.
  3. Moran BJ, Mukherjee A, Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg 2006; 93(1):100-4.
  4. Mahteme H, von Heideman A, Grundmark B, Tholander B, Påhlman L, Glimelius B et al. Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis. Eur J Surg Oncol 2007; Jun 15; : 17574369
  5. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av kreft i tykktarm og endetarm. IS-2283, feb 2015 (ISBN 978-82-8081-367-1)
  6. Evers DJ, Verwaal VJ. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin. Br J Surg. 2011 Feb;98(2):287-92.
  7. Carr NJ, Cecil TD, Mohammed F, Sobin LH, Sugarbaker PH, Gonzalez-Morene,S et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia. Am J Surg Pathol 2016; 40:14-26.
  8. Froysnes IS1, Larsen SG1, Spasojevic M, Dueland S, Flatmark K.. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort. J Surg Oncol 2016;DOI 10.1002/jso.24290.

  9. Van Leeuwen BL, Graf W, Pahlman L, Mahteme H. Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis. Ann Surg Oncol 2007; 12(5).
  10. Sugarbaker PH. Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture. Can J Surg 1989; 32(3):164-70.
  11. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42.
  12. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6(8):727-31.
  13. Sugarbaker PH. A curative approach to peritoneal carcinomatosis from colorectal cancer. Semin Oncol 2005; 32(6 Suppl 9):S68-S73.
  14. Elias D, Bedard V, Bouzid T, Duvillard P, Kohneh-Sharhi N, Raynard B et al. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol 2007; 31(10):784-8.
  15. Yan TD, Morris DL. Cytoreductive  surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: Experimental therapy or standard of care? Ann Surg 2008; 248(5):829-835.
  16. Franco J et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer.   Ann Surg Oncol 2008;15(11):3065-3072.
  17. Elias DJ et al. Coplete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. Clin Oncol 2009;27(5):681-685.
  18. Yan TD et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutial experience. J Clin Oncol 2009;27(36):6237-6242.
  19. L-OUS-033 Perfusjonskjemoterapi: Nasjonal behandlingstjeneste for hyperterm intraperitoneal kjemoterapi ved kolorektal kreft, pseudomyxoma peritonei og peritonealt mesoteliom).
  20. Sorensen O. Flatmark K, Dueland S, Giercksky K-E, Larsen SG.. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in pseudomyxoma peritonei. Eur J Surg Oncol. 2012 Oct;38(10):969-76.
  21. Mirnezami R, Mehta AM, Chandrakumaran K, Cecil T, Moran BJ, Carr N, Verwaal VJ, Mohamed F, Mirnezami AH. Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer. 2014 Oct 14;111(8):1500-8.
  22. Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009;27:681-85.
  23. Verwaal VJ, Bruin S, Boot H, Van Slooten G, Van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008;15:2426-2432.

Prosedyrer i Oncolex kan ikke erstatte faglig veiledning fra kvalifisert veileder. Den som følger prosedyrene har et selvstendig ansvar for at det foreligger nødvendig godkjenning, lisens eller autorisasjon.
Oslo universitetssykehus HF © 2016